Valterra Platinum Limited (LON:VALT)

Ligand Pharmaceuticals Revenue

Valterra Platinum had revenue of 42.34B ZAR in the half year ending June 30, 2025, a decrease of -34.54%. This brings the company's revenue in the last twelve months to 99.11B, down -11.60% year-over-year. In the year 2024, Valterra Platinum had annual revenue of 108.99B, down -12.52%.

• Revenue (ttm): 99.11B ZAR
• Revenue Growth: -11.60%
• P/S Ratio: 2.20
• Revenue / Employee: 4.92M ZAR
• Employees: 20,158
• Market Cap: 8.98B USD

Revenue Chart

* This company reports financials in ZAR.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	108.99B	-15.60B	-12.52%
Dec 31, 2023	124.58B	-39.51B	-24.08%
Dec 31, 2022	164.09B	-50.48B	-23.53%
Dec 31, 2021	214.57B	106.80B	99.10%
Dec 31, 2020	107.77B	8.22B	8.26%